FdaApplication
NDA 203050
Identifiers
- fda_app_no: NDA203050
Properties
| Property | Value |
|---|---|
| applicant_name | AVYXA HOLDINGS LLC |
| application_type | NDA |
| approval_date | 2016-03-01 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| POSFREA | PALONOSETRON HYDROCHLORIDE | EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML) | SOLUTION;INTRAVENOUS |
| POSFREA | PALONOSETRON HYDROCHLORIDE | EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) | SOLUTION;INTRAVENOUS |
2 products